Characterization of valproic acid‐initiated homologous recombination

作者: Kevin Sha , Louise M. Winn

DOI: 10.1002/BDRB.20236

关键词:

摘要: BACKGROUND: Valproic acid (VPA) is a frequently used antiepileptic agent and known teratogen. Previous research suggests that inhibition of histone deacetylases (HDACs) may play role in VPA-induced teratogenicity. We have also shown VPA exposure leads to both an increase reactive oxygen species (ROS) production increased frequency homologous recombination (HR). METHODS: In the present study, we evaluated HDAC VPA-initiated HR determine if could alter repair activity and/or cause DNA double-strand breaks (DSBs), which would then initiate repair. Histone acetylation status was assessed led CHO 33 cells. RESULTS: Our results demonstrate (5 mM) acetylated H3 H4 protein levels after 10 24 hr. Secondly, our assay where artificial DSB induced cells assess activity, did not affect HR. Subsequently, susceptibility DSBs, number γ-H2AX foci using immunocytochemistry revealed 10- 24-hr VPA. CONCLUSIONS: Although demonstrated protective effect polyethylene glycol-catalase against generation intracellular ROS within 24 hr, observed oxidation. These studies suggest signaling roles maintenance cell-cycle arrest initiating damage Birth Defects Res (Part B) 89:124–132, 2010. © 2010 Wiley-Liss, Inc.

参考文章(150)
Charles B. Nemeroff, Michael J. Owens, Pharmacology of valproate. Psychopharmacology Bulletin. pp. 17- 24 ,(2003)
Hiroaki Nakamura, Fumihiko Ushigome, Noriko Koyabu, Shoji Satoh, Kiyomi Tsukimori, Hitoo Nakano, Hisakazu Ohtani, Yasufumi Sawada, None, Proton gradient-dependent transport of valproic acid in human placental brush-border membrane vesicles Pharmaceutical Research. ,vol. 19, pp. 154- 161 ,(2002) , 10.1023/A:1014242931475
Belén Gómez-González, Andrés Aguilera, Benjamín Pardo, DNA double-strand break repair: how to fix a broken relationship Cellular and Molecular Life Sciences. ,vol. 66, pp. 1039- 1056 ,(2009) , 10.1007/S00018-009-8740-3
Ramune Reliene, Alexander J.R. Bishop, Robert H. Schiestl, Involvement of homologous recombination in carcinogenesis. Advances in Genetics. ,vol. 58, pp. 67- 87 ,(2007) , 10.1016/S0065-2660(06)58003-4
John M. Fortune, Neil Osheroff, Topoisomerase II as a target for anticancer drugs: when enzymes stop being nice. Progress in Nucleic Acid Research and Molecular Biology. ,vol. 64, pp. 221- 253 ,(2000) , 10.1016/S0079-6603(00)64006-0
T. Nouspikel, DNA repair in mammalian cells : Nucleotide excision repair: variations on versatility. Cellular and Molecular Life Sciences. ,vol. 66, pp. 994- 1009 ,(2009) , 10.1007/S00018-009-8737-Y
Alfred G. Knudson, Two genetic hits (more or less) to cancer Nature Reviews Cancer. ,vol. 1, pp. 157- 162 ,(2001) , 10.1038/35101031